CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 160 filers reported holding CRISPR THERAPEUTICS AG in Q4 2018. The put-call ratio across all filers is 1.91 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $12,855,106 | +24.1% | 228,983 | 0.0% | 1.21% | +47.6% |
| Q1 2023 | $10,356,901 | +11.3% | 228,983 | 0.0% | 0.82% | -42.7% |
| Q4 2022 | $9,308,159 | -25.1% | 228,983 | +20.4% | 1.43% | +15.1% |
| Q3 2022 | $12,428,000 | -36.8% | 190,183 | -41.3% | 1.24% | -37.2% |
| Q2 2022 | $19,676,000 | +30.2% | 323,783 | +34.5% | 1.98% | +14.1% |
| Q1 2022 | $15,108,000 | +12.1% | 240,683 | +35.3% | 1.73% | +6.3% |
| Q4 2021 | $13,480,000 | -60.9% | 177,883 | -42.2% | 1.63% | -49.7% |
| Q3 2021 | $34,441,000 | -30.9% | 307,700 | 0.0% | 3.24% | -13.4% |
| Q2 2021 | $49,814,000 | +32.9% | 307,700 | 0.0% | 3.74% | +157.6% |
| Q1 2021 | $37,493,000 | -31.1% | 307,700 | -13.4% | 1.45% | -38.9% |
| Q4 2020 | $54,385,000 | +38.9% | 355,200 | -24.1% | 2.38% | +16.3% |
| Q3 2020 | $39,160,000 | +13.8% | 468,200 | 0.0% | 2.04% | -40.3% |
| Q2 2020 | $34,408,000 | +73.3% | 468,200 | 0.0% | 3.42% | +65.9% |
| Q1 2020 | $19,856,000 | +20.0% | 468,200 | +72.3% | 2.06% | +6.8% |
| Q4 2019 | $16,548,000 | +48.6% | 271,700 | 0.0% | 1.93% | +218.0% |
| Q3 2019 | $11,137,000 | -13.0% | 271,700 | 0.0% | 0.61% | -41.5% |
| Q2 2019 | $12,797,000 | +31.9% | 271,700 | 0.0% | 1.04% | +19.2% |
| Q1 2019 | $9,705,000 | +25.0% | 271,700 | 0.0% | 0.87% | +19.0% |
| Q4 2018 | $7,762,000 | -35.6% | 271,700 | 0.0% | 0.73% | -31.3% |
| Q3 2018 | $12,050,000 | – | 271,700 | – | 1.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gilfoyle Management LLC | 150 | $6,376 | 12.96% |
| Versant Venture Management, LLC | 498,558 | $22,629,548 | 12.03% |
| NEA Management Company, LLC | 1,587,854 | $72,072,693 | 5.57% |
| ARK Investment Management | 7,163,118 | $325,133,913 | 2.49% |
| Nikko Asset Management Americas, Inc. | 3,465,470 | $157,263,029 | 1.88% |
| Integral Health Asset Management, LLC | 275,000 | $12,482,250 | 1.73% |
| Merlin Capital, Inc | 9,092 | $412,686 | 1.54% |
| Del-Sette Capital Management, LLC | 33,977 | $1,542,216 | 1.52% |
| Green Alpha Advisors, LLC | 34,880 | $1,583,203 | 1.22% |
| Ikarian Capital, LLC | 2,039 | $9,255,021 | 1.11% |